| 1,2,4-trimethylbenzene | decreases expression | EXP | | 6480464 | pseudocumene results in decreased expression of NME1 protein | CTD | PMID:17337753 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol affects the expression of NME1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:16174780 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:17942748 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:17942748 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:16467188 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:16174780 more ... |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:16174780 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:735394 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NME1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:735394 | 6480464 | Ethinyl Estradiol results in increased expression of NME1 mRNA | CTD | PMID:16467188 more ... |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:735394 | 6480464 | fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased expression of NME1 mRNA] | CTD | PMID:16467188 |
| 17beta-estradiol | increases expression | ISO | RGD:735393 | 6480464 | Estradiol results in increased expression of NME1 mRNA | CTD | PMID:22609851 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735394 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NME1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735394 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NME1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735394 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NME1 mRNA | CTD | PMID:17942748 PMID:16467188 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735394 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NME1 mRNA | CTD | PMID:16467188 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735394 | 6480464 | fulvestrant inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NME1 mRNA] | CTD | PMID:16467188 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of NME1 mRNA | CTD | PMID:21346803 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:735394 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NME1 mRNA | CTD | PMID:20188158 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:735394 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NME1 mRNA | CTD | PMID:20188158 |
| 5-fluorouracil | affects response to substance | ISO | RGD:735393 | 6480464 | NME1 protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 |
| aflatoxin B1 | affects expression | ISO | RGD:735393 | 6480464 | Aflatoxin B1 affects the expression of NME1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:735393 | 6480464 | Aflatoxin B1 results in increased expression of NME1 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:735393 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of NME1 mRNA | CTD | PMID:16443354 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:735393 | 6480464 | Tretinoin results in decreased expression of NME1 mRNA | CTD | PMID:16054129 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NME1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:735393 | 6480464 | Benzo(a)pyrene results in increased expression of NME1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:735393 | 6480464 | Benzo(a)pyrene results in increased expression of NME1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | increases expression | ISO | RGD:735393 | 6480464 | Benzo(a)pyrene results in increased expression of NME1 protein | CTD | PMID:20097212 |
| cisplatin | increases expression | ISO | RGD:735393 | 6480464 | Cisplatin results in increased expression of NME1 protein | CTD | PMID:21924258 |
| cisplatin | increases expression | ISO | RGD:735393 | 6480464 | Cisplatin results in increased expression of NME1 protein | CTD | PMID:20540955 PMID:21924258 |
| clofibrate | increases expression | ISO | RGD:735394 | 6480464 | Clofibrate results in increased expression of NME1 mRNA | CTD | PMID:17585979 |
| cobalt dichloride | decreases expression | ISO | RGD:735393 | 6480464 | cobaltous chloride results in decreased expression of NME1 mRNA | CTD | PMID:19376846 |
| copper atom | multiple interactions | ISO | RGD:735393 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Copper results in increased expression of NME1 mRNA] | CTD | PMID:16629173 |
| copper atom | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Copper | CTD | PMID:14534351 PMID:15359738 |
| copper atom | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Copper | CTD | PMID:15359738 |
| copper(0) | multiple interactions | ISO | RGD:735393 | 6480464 | [MT1 protein co-treated with MT2 protein] affects the reaction [Copper results in increased expression of NME1 mRNA] | CTD | PMID:16629173 |
| copper(0) | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Copper | CTD | PMID:14534351 PMID:15359738 |
| copper(0) | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Copper | CTD | PMID:15359738 |
| curcumin | increases expression | ISO | RGD:735393 | 6480464 | Curcumin results in increased expression of NME1 mRNA | CTD | PMID:17198877 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of NME1 mRNA | CTD | PMID:11599041 |
| cyclosporin A | increases expression | ISO | RGD:735393 | 6480464 | Cyclosporine results in increased expression of NME1 mRNA | CTD | PMID:20106945 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:735393 | 6480464 | Tetrahydrocannabinol results in decreased expression of NME1 mRNA | CTD | PMID:18454173 |
| diarsenic trioxide | increases expression | ISO | RGD:735393 | 6480464 | arsenic trioxide results in increased expression of NME1 mRNA | CTD | PMID:12478894 |
| diarsenic trioxide | increases expression | ISO | RGD:735394 | 6480464 | arsenic trioxide results in increased expression of NME1 protein | CTD | PMID:19822495 |
| diarsenic trioxide | increases expression | ISO | RGD:735393 | 6480464 | arsenic trioxide results in increased expression of NME1 protein | CTD | PMID:12452020 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NME1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of NME1 mRNA | CTD | PMID:17379624 |
| diethylstilbestrol | increases expression | ISO | RGD:735393 | 6480464 | Diethylstilbestrol results in increased expression of NME1 mRNA | CTD | PMID:15766595 |
| ethanol | increases expression | ISO | RGD:735393 | 6480464 | Ethanol results in increased expression of NME1 protein | CTD | PMID:20621659 |
| fulvestrant | multiple interactions | ISO | RGD:735393 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of NME1 mRNA | CTD | PMID:19016759 |
| fulvestrant | multiple interactions | ISO | RGD:735394 | 6480464 | fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased expression of NME1 mRNA]; more ... | CTD | PMID:16467188 |
| fulvestrant | decreases expression | ISO | RGD:735393 | 6480464 | fulvestrant results in decreased expression of NME1 mRNA | CTD | PMID:19016759 |
| graphite | decreases expression | ISO | RGD:735393 | 6480464 | Graphite results in decreased expression of NME1 protein | CTD | PMID:22157353 |
| hydralazine | multiple interactions | ISO | RGD:735393 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA | CTD | PMID:17183730 |
| hydrogen peroxide | increases expression | ISO | RGD:735393 | 6480464 | Hydrogen Peroxide results in increased expression of NME1 mRNA | CTD | PMID:18951874 |
| indomethacin | increases expression | ISO | RGD:735393 | 6480464 | Indomethacin results in increased expression of NME1 mRNA | CTD | PMID:12192599 |
| L-ascorbic acid | multiple interactions | ISO | RGD:735393 | 6480464 | [Tretinoin co-treated with Ascorbic Acid] results in decreased expression of NME1 mRNA | CTD | PMID:16443354 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:735394 | 6480464 | Diethylnitrosamine results in increased expression of NME1 protein | CTD | PMID:15928304 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of NME1 mRNA | CTD | PMID:19638242 |
| okadaic acid | multiple interactions | ISO | RGD:735393 | 6480464 | [Okadaic Acid co-treated with gambierol] results in decreased expression of NME1 protein | CTD | PMID:19397276 |
| okadaic acid | decreases expression | ISO | RGD:735393 | 6480464 | Okadaic Acid results in decreased expression of NME1 protein | CTD | PMID:19397276 |
| paclitaxel | increases expression | EXP | | 6480464 | Paclitaxel results in increased expression of NME1 mRNA | CTD | PMID:15585946 |
| paracetamol | affects expression | ISO | RGD:735394 | 6480464 | Acetaminophen affects the expression of NME1 mRNA | CTD | PMID:17562736 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of NME1 mRNA | CTD | PMID:17935786 |
| phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of NME1 mRNA | CTD | PMID:17616710 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of NME1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:735394 | 6480464 | pirinixic acid results in increased expression of NME1 mRNA | CTD | PMID:18301758 |
| sirolimus | multiple interactions | ISO | RGD:735393 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of NME1 mRNA | CTD | PMID:19016759 |
| sulforaphane | increases metabolic processing | ISO | RGD:735393 | 6480464 | sulforafan results in increased metabolism of NME1 protein | CTD | PMID:21838287 |
| sulforaphane | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to sulforafan | CTD | PMID:21838287 |
| tamoxifen | affects expression | ISO | RGD:735394 | 6480464 | Tamoxifen affects the expression of NME1 mRNA | CTD | PMID:17555576 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of NME1 mRNA | CTD | PMID:12734012 |
| trimellitic anhydride | increases expression | ISO | RGD:735394 | 6480464 | trimellitic anhydride results in increased expression of NME1 mRNA | CTD | PMID:19042947 |
| undecane | decreases expression | EXP | | 6480464 | undecane results in decreased expression of NME1 protein | CTD | PMID:17337753 |
| valproic acid | multiple interactions | ISO | RGD:735393 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of NME1 mRNA | CTD | PMID:17183730 |
| valproic acid | affects expression | ISO | RGD:735394 | 6480464 | Valproic Acid affects the expression of NME1 mRNA | CTD | PMID:17292431 |
| zinc atom | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Zinc | CTD | PMID:14534351 |
| zinc atom | decreases expression | ISO | RGD:735393 | 6480464 | Zinc deficiency results in decreased expression of NME1 mRNA | CTD | PMID:12888634 |
| zinc(0) | affects binding | ISO | RGD:735393 | 6480464 | NME1 protein binds to Zinc | CTD | PMID:14534351 |
| zinc(0) | decreases expression | ISO | RGD:735393 | 6480464 | Zinc deficiency results in decreased expression of NME1 mRNA | CTD | PMID:12888634 |